...
【24h】

Molecular basis of telomere syndrome caused by CTC1 mutations

机译:CTC1突变引起的端粒综合征的分子基础

获取原文
获取原文并翻译 | 示例
           

摘要

Mutations in CTC1 lead to the telomere syndromes Coats Plus and dyskeratosis congenita (DC), but the molecular mechanisms involved remain unknown. CTC1 forms with STN1 and TEN1 a trimeric complex termed CST, which binds ssDNA, promotes telomere DNA synthesis, and inhibits telomerase-mediated telomere elongation. Here we identify CTC1 disease mutations that disrupt CST complex formation, the physical interaction with DNA polymerase a-primase (polα-primase), telomeric ssDNA binding in vitro, accumulation in the nucleus, and/or telomere association in vivo. While having diverse molecular defects, CTC1 mutations commonly lead to the accumulation of internal single-stranded gaps of telomeric DNA, suggesting telomere DNA replication defects as a primary cause of the disease. Strikingly, mutations in CTC1 may also unleash telomerase repression and telomere length control. Hence, the telomere defect initiated by CTC1 mutations is distinct from the telomerase insufficiencies seen in classical forms of telomere syndromes, which cause short telomeres due to reduced maintenance of distal telomeric ends by telomerase. Our analysis provides molecular evidence that CST collaborates with DNA polα-primase to promote faithful telomere DNA replication.
机译:CTC1中的突变会导致端粒综合征Coats Plus和先天性角化不全(DC),但涉及的分子机制仍然未知。 CTC1与STN1和TEN1形成称为CST的三聚体复合物,该复合物与ssDNA结合,促进端粒DNA的合成,并抑制端粒酶介导的端粒伸长。在这里,我们确定了破坏CST复合物形成,与DNA聚合酶α-primase(polα-primase)的物理相互作用,在体外结合的端粒ssDNA,在细胞核中积累和/或端粒缔合的CTC1疾病突变。尽管具有各种分子缺陷,但CTC1突变通常导致端粒DNA内部单链间隙的积累,提示端粒DNA复制缺陷是该疾病的主要原因。令人惊讶的是,CTC1中的突变也可能释放端粒酶阻抑和端粒长度控制。因此,由CTC1突变引发的端粒缺陷与经典形式的端粒综合征所见的端粒酶功能不全不同,端粒酶综合征由于端粒酶对远端端粒末端的保留减少而导致端粒短。我们的分析提供了分子生物学证据,表明CST与DNApolα-primase协同作用可促进忠实的端粒DNA复制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号